Allergies News and Research

Latest Allergies News and Research

UT Southwestern Medical Center among 10 institutions to share $56 million from NIH as part of ICAC

UT Southwestern Medical Center is among 10 institutions selected by the National Institutes of Health to share $56 million over five years as part of the Inner City Asthma Consortium (ICAC).

23 Nov 2009

Eclipsys reaches milestone: 50 millionth order entered into its EHR system

Eclipsys Corporation®, The Outcomes Company®, continues to strengthen its position as a leader in computerized physician order entry (CPOE) with the announcement today that long-standing client Sarasota Memorial Health Care System (Sarasota Memorial), located in Sarasota, FL, recently entered its 50 millionth order into its electronic health record (EHR) system. The notable physician order was entered by emergency medicine specialist Bill Colgate, MD.

23 Nov 2009

UT Southwestern Medical Center receives NIH funds for asthma research

UT Southwestern Medical Center is among 10 institutions selected by the National Institutes of Health to share $56 million over five years as part of the Inner City Asthma Consortium (ICAC).

23 Nov 2009

Air pollution linked with respiratory symptoms in young inner-city children: Study

Exposure shortly after birth to ambient metals from fuel oil combustion and particles from diesel emissions is associated with respiratory symptoms in young inner-city children, according to a new study by researchers at the Columbia Center for Children's Environmental Health (CCCEH) at Columbia University's Mailman School of Public Health.

23 Nov 2009

Children exposed to pollution and indoor allergens face increased risk of asthma

Children who are exposed to high levels of traffic-related pollution and high levels of indoor endotoxin early in life have six times the risk of developing persistent wheezing by age three than children exposed to low levels of traffic and indoor-related pollutants, according to new research from the University of Cincinnati College of Medicine.

23 Nov 2009

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

23 Nov 2009

Bacteria help in preventing inflammation after skin injury

On the skin's surface, bacteria are abundant, diverse and constant, but inflammation is undesirable. Research at the University of California, San Diego School of Medicine now shows that the normal bacteria living on the skin surface trigger a pathway that prevents excessive inflammation after injury.

22 Nov 2009

Stop & Shop Supermarket warns customers to discard unused portions of recalled products by Unilever

Following a recall by Unilever The Stop & Shop Supermarket Company removed from sale Shedd's Country Crock ® Side Dishes DELUXE Cheddar Broccoli Rice and Shedd's Country Crock ® Side Dishes DELUXE Four Cheese Pasta due to an undeclared sulfite allergen.

21 Nov 2009

ENTA opens new medical offices in Edison and Old Bridge

ENT and Allergy Associates LLP (ENTA) is pleased to announce a significant expansion of their practice, with the opening of 2 new locations-in Edison and Old Bridge, New Jersey. These State-of-the-art medical offices will serve the growing population of Middlesex County, with physicians and clinical staff providing full service Otolaryngology, Audiology and Allergy medical services. This expansion includes the merging of Dr. Gerald Scott’s existing Edison and Old Bridge practice into ENTA, effective immediately.

21 Nov 2009

Unilever and FDA recall certain Shedd’s Country Crock chilled side-dish products

Unilever United States, Inc., of Englewood Cliffs, NJ, in cooperation with the U.S. Food and Drug Administration (FDA), is voluntarily recalling certain Shedd’s Country Crock® chilled side-dish products because they may contain undeclared sulfites.

21 Nov 2009

Multi-state electronic tracking program to prevent diversion of common medicines for methamphetamine production

The National Association of Drug Diversion Investigators (NADDI) today announced a new initiative in the war on methamphetamine. The National Precursor Log Exchange (NPLEx) is a multi-state electronic tracking program that enforces purchase limitations on over-the-counter (OTC) medicines containing pseudoephedrine in real-time at the point of sale.

21 Nov 2009

Discovery holds promise in fighting cancer, AIDS and autoimmune disorders

21 Nov 2009

Soligenix receives $9.4M NIAID grant to develop technology for advancing rapidly acting vaccines

Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has formed a consortium to develop thermostable technology to advance RiVax(TM) and other rapidly acting vaccines. Soligenix received a $9.4 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to support this work.

20 Nov 2009

Discovery of Th22 cells may help in developing effective therapies for chronic skin and respiratory diseases

The newly discovered Th22 cells are a previously unknown subset of T helper cells. T helper cells are white blood cells that help activate other immune cells when the body is infected by viruses or bacteria. At the same time they help the body to tolerate own tissue and to prevent or curb inflammation.

20 Nov 2009

Positive results from recently completed phase II clinical study of ToleroMune therapy announced

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced positive results from a recently completed phase II clinical study of its ToleroMune(R) cat allergy therapy, which successfully identified the optimal dosing regimens to progress into late-stage development.

20 Nov 2009

Discoveries on anti-HIV antibodies may help researchers create an effective HIV vaccine

New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

20 Nov 2009

Detrimental bacterial DNA identification method for use in winemaking developed

In winemaking, grape juice is turned to wine during the fermentation process by the action of a number of essential beneficial microorganisms -namely bacteria. Sometimes, though, harmful bacteria also populate the fermentation vat, spoiling the wine in the process.

20 Nov 2009

Sugar-coated polymer may offer a new solution for allergy and asthma

Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Their advance is a significant step toward crafting pharmaceuticals to fight these often life-endangering conditions in a new way.

20 Nov 2009

Altair Therapeutics initiates its IL-4 receptor alpha inhibitor bronchoprovocation phase 2 trial

Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.

19 Nov 2009

Genetic identity of cellular receptor for the immune system's first-response antibody discovered

Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. The discovery is such a crucial part of immunology that UAB researchers, in conjunction with Japanese researchers, are asking that the gene linked to this antibody receptor be renamed to better describe its role in early immune responses.

19 Nov 2009

Allergies News and Research

Latest Allergies News and Research

UT Southwestern Medical Center among 10 institutions to share $56 million from NIH as part of ICAC

Eclipsys reaches milestone: 50 millionth order entered into its EHR system

UT Southwestern Medical Center receives NIH funds for asthma research

Air pollution linked with respiratory symptoms in young inner-city children: Study

Children exposed to pollution and indoor allergens face increased risk of asthma

New target may promote development of novel therapies for chronic sinusitis

Bacteria help in preventing inflammation after skin injury

Stop & Shop Supermarket warns customers to discard unused portions of recalled products by Unilever

ENTA opens new medical offices in Edison and Old Bridge

Unilever and FDA recall certain Shedd’s Country Crock chilled side-dish products

Multi-state electronic tracking program to prevent diversion of common medicines for methamphetamine production

Discovery holds promise in fighting cancer, AIDS and autoimmune disorders

Soligenix receives $9.4M NIAID grant to develop technology for advancing rapidly acting vaccines

Discovery of Th22 cells may help in developing effective therapies for chronic skin and respiratory diseases

Positive results from recently completed phase II clinical study of ToleroMune therapy announced

Discoveries on anti-HIV antibodies may help researchers create an effective HIV vaccine

Detrimental bacterial DNA identification method for use in winemaking developed

Sugar-coated polymer may offer a new solution for allergy and asthma

Altair Therapeutics initiates its IL-4 receptor alpha inhibitor bronchoprovocation phase 2 trial

Genetic identity of cellular receptor for the immune system's first-response antibody discovered

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Allergies News and Research

Latest Allergies News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in